Literature DB >> 33321819

Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Tomasz M Grzywa1,2,3, Klaudia Klicka1,2, Paweł K Włodarski1.   

Abstract

Tumor cell invasiveness and metastasis are the main causes of mortality in cancer. Tumor progression is composed of many steps, including primary tumor growth, local invasion, intravasation, survival in the circulation, pre-metastatic niche formation, and metastasis. All these steps are strictly controlled by microRNAs (miRNAs), small non-coding RNA that regulate gene expression at the post-transcriptional level. miRNAs can act as oncomiRs that promote tumor cell invasion and metastasis or as tumor suppressor miRNAs that inhibit tumor progression. These miRNAs regulate the actin cytoskeleton, the expression of extracellular matrix (ECM) receptors including integrins and ECM-remodeling enzymes comprising matrix metalloproteinases (MMPs), and regulate epithelial-mesenchymal transition (EMT), hence modulating cell migration and invasiveness. Moreover, miRNAs regulate angiogenesis, the formation of a pre-metastatic niche, and metastasis. Thus, miRNAs are biomarkers of metastases as well as promising targets of therapy. In this review, we comprehensively describe the role of various miRNAs in tumor cell migration, invasion, and metastasis.

Entities:  

Keywords:  cell migration; epithelial–mesenchymal transition; metastasis; miRNA; oncomiR; tumor invasiveness; tumor suppressor miR

Year:  2020        PMID: 33321819      PMCID: PMC7763175          DOI: 10.3390/cancers12123709

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  574 in total

1.  MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.

Authors:  Jinhai Li; Yuanyuan Guo; Xiaodi Liang; Ming Sun; Guoliang Wang; Wei De; Wenxi Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-22       Impact factor: 4.553

2.  miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer.

Authors:  Zhenguo Cheng; Funan Liu; Guanqiao Wang; Yanshu Li; Hongyan Zhang; Feng Li
Journal:  Cell Signal       Date:  2014-08-22       Impact factor: 4.315

3.  miR-214 down-regulates MKK3 and suppresses malignant phenotypes of cervical cancer cells.

Authors:  Ruiqing Peng; Xiangshan Cheng; Yue Zhang; Xin Lu; Zhidong Hu
Journal:  Gene       Date:  2019-10-18       Impact factor: 3.688

4.  MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway.

Authors:  Guanlin Tang; Ruoyang Du; Zhaobing Tang; Youlin Kuang
Journal:  J Cell Biochem       Date:  2018-01-09       Impact factor: 4.429

5.  Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Christine Earle; Katherine Krueger; Christina C Spevak
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

6.  Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.

Authors:  Tomohiro Umezu; Hiroko Tadokoro; Kenko Azuma; Seiichiro Yoshizawa; Kazuma Ohyashiki; Junko H Ohyashiki
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

7.  MiR-199a-5p Inhibits the Growth and Metastasis of Colorectal Cancer Cells by Targeting ROCK1.

Authors:  Qian Dong Zhu; Qing Qing Zhou; Lemei Dong; Zhiming Huang; Fang Wu; Xia Deng
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

Review 8.  Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex.

Authors:  Youn-Sang Jung; Jae-Il Park
Journal:  Exp Mol Med       Date:  2020-02-10       Impact factor: 8.718

9.  Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.

Authors:  T Kinoshita; N Nohata; T Hanazawa; N Kikkawa; N Yamamoto; H Yoshino; T Itesako; H Enokida; M Nakagawa; Y Okamoto; N Seki
Journal:  Br J Cancer       Date:  2013-10-03       Impact factor: 7.640

10.  miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.

Authors:  Violaine Tribollet; Bruno Barenton; Auriane Kroiss; Séverine Vincent; Ling Zhang; Christelle Forcet; Catherine Cerutti; Séverine Périan; Nathalie Allioli; Jacques Samarut; Jean-Marc Vanacker
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more
  7 in total

1.  MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc.

Authors:  Eleni Anastasiadou; Elena Messina; Tiziana Sanavia; Lucia Mundo; Federica Farinella; Stefano Lazzi; Francesca Megiorni; Simona Ceccarelli; Paola Pontecorvi; Francesco Marampon; Cira Rosaria Tiziana Di Gioia; Giorgia Perniola; Pierluigi Benedetti Panici; Lorenzo Leoncini; Pankaj Trivedi; Andrea Lenzi; Cinzia Marchese
Journal:  Cells       Date:  2021-03-01       Impact factor: 6.600

Review 2.  The Significant Role of the Microfilament System in Tumors.

Authors:  Xin Jiang; Yiming Qin; Liu Kun; Yanhong Zhou
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

3.  microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.

Authors:  Maria Mortoglou; Francesc Miralles; Elif Damla Arisan; Alwyn Dart; Stipo Jurcevic; Sigrun Lange; Pinar Uysal-Onganer
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

4.  Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma.

Authors:  Chia-Hsin Liu; Shu-Hsuan Liu; Yo-Liang Lai; Yi-Chun Cho; Fang-Hsin Chen; Li-Jie Lin; Pei-Hua Peng; Chia-Yang Li; Shu-Chi Wang; Ji-Lin Chen; Heng-Hsiung Wu; Min-Zu Wu; Yuh-Pyng Sher; Wei-Chung Cheng; Kai-Wen Hsu
Journal:  Comput Struct Biotechnol J       Date:  2022-08-22       Impact factor: 6.155

Review 5.  The role of miR-200 family in the regulation of hallmarks of cancer.

Authors:  Klaudia Klicka; Tomasz M Grzywa; Aleksandra Mielniczuk; Alicja Klinke; Paweł K Włodarski
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

Review 6.  Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications.

Authors:  Roman Uzhachenko; Akiko Shimamoto; Sanika S Chirwa; Sergey V Ivanov; Alla V Ivanova; Anil Shanker
Journal:  Cancer Gene Ther       Date:  2022-02-18       Impact factor: 5.854

Review 7.  A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression.

Authors:  Rhafaela Lima Causin; Ana Julia Aguiar de Freitas; Cassio Murilo Trovo Hidalgo Filho; Ricardo Dos Reis; Rui Manuel Reis; Márcia Maria Chiquitelli Marques
Journal:  Cells       Date:  2021-03-17       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.